SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Peptides derived from proteolytic processing of the beta-amyloid precursor protein (APP), including the amyloid-beta peptide, are important for the pathogenesis of Alzheimer's dementia. We found that transgenic mice overexpressing APP have a profound and selective impairment in endothelium-dependent regulation of the neocortical microcirculation. Such endothelial dysfunction was not found in transgenic mice expressing both APP and superoxide dismutase-1 (SOD1) or in APP transgenics in which SOD was topically applied to the cerebral cortex. These cerebrovascular effects of peptides derived from APP processing may contribute to the alterations in cerebral blood flow and to neuronal dysfunction in Alzheimer's dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
In the citing paper
“Converging evidence suggests that amyloid-β and tau-related pathology contribute to chronic hypoperfusion of white matter tissue (Iadecola et al., 1999; Park et al., 2008).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Iadecola et al., 1999
In the citing paper
“Through these additional substrates, BACE1 has been implicated in inflammation, cardiovascular function, glucose homeostasis, and insulin signaling”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [37]
In the citing paper
“The vascular alterations induced by Aβ are abrogated by overexpression of the ROS scavenging enzyme superoxide dismutase or deficiency of the NADPH oxidase subunit NOX2 (Iadecola et al., 1999; Park et al., 2005; 2008)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Iadecola et al., 1999
In the citing paper
“overexpression of SOD1 in APP-overexpressing mice abolishes the lethal effects of the APP overexpression (40, 26).”
From Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes (2019) · cites this paper as [26]
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Self-citationA Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
FARACI, F. M., & HEISTAD, D. D. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.53 · Cited by 780
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703
The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., & Beyreuther, K. (1996) · Science · doi:10.1126/science.271.5254.1406 · Cited by 678
Research works printed but not linked: 1
- Stamler, J. S. A radical vascular connection. Nature 380, 108–111 (1996).
Cited by
Items 201–300 of 420
Characterization of the role of metallothionein-3 in an animal model of Alzheimer’s disease
Manso, Y., Carrasco, J., Comes, G., Meloni, G., Adlard, P. A., Bush, A. I., Vašák, M., & Hidalgo, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1047-9 · Cited by 63
Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy
Nath, A. K., Enciso, J., Kuniyasu, M., Hao, X.-Y., Madri, J. A., & Pinter, E. (2004) · Development · doi:10.1242/dev.01131 · Cited by 63
Fukuo, K., Yang, J., Yasuda, O., Mogi, M., Suhara, T., Sato, N., Suzuki, T., Morimoto, S., & Ogihara, T. (2002) · Circulation · doi:10.1161/01.cir.0000021924.02006.ba · Cited by 63
Giovannini, M. G., Lana, D., Traini, C., & Vannucchi, M. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112358 · Cited by 61
Circulating Endothelin-1 Alters Critical Mechanisms Regulating Cerebral Microcirculation
Faraco, G., Moraga, A., Moore, J., Anrather, J., Pickel, V. M., & Iadecola, C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01761 · Cited by 61
Self-citationtPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β
Park, L., Zhou, J., Koizumi, K., Wang, G., Anfray, A., Ahn, S. J., Seo, J., Zhou, P., Zhao, L., Paul, S. M., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1140-20.2020 · Cited by 60
Self-citationKisler, K., Lazić, D., Sweeney, M. D., Plunkett, S., Khatib, M. E., Vinogradov, S. A., Boas, D. A., Sakadžić, S., & Zloković, B. V. (2018) · Nature Protocols · doi:10.1038/nprot.2018.034 · Cited by 58
Fujita, K., Yamafuji, M., Nakabeppu, Y., & Noda, M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/324256 · Cited by 57
Membrane Biophysics and Mechanics in Alzheimer's Disease
Yang, X., Askarova, S., & Lee, J. C.-M. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8121-9 · Cited by 48
Leung, M. C. P., Yip, K. K., Ho, J. Y. S., Siu, F. K. W., Li, W. C., & Garner, B. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9550-4 · Cited by 55
Harris‐Cerruti, C., Kamsler, A., Kaplan, B., Lamb, B., Segal, M., & Groner, Y. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03188.x · Cited by 47
Raffa, D. F., Rickard, G. A., & Rauk, A. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0175-9 · Cited by 54
Baumbach, G. L., Didion, S. P., & Faraci, F. M. (2006) · Stroke · doi:10.1161/01.str.0000227236.84546.5a · Cited by 53
Zerbi, V. (2013) · Radboud Repository (Radboud University) · Cited by 54
Borg, J., & London, J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10404 · Cited by 53
Deininger, M. H., Fimmen, B. A., Thal, D. R., Schluesener, H. J., & Meyermann, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10621.2002 · Cited by 53
Kouznetsova, E., Klingner, M., Sorger, D., Sabri, O., Großmann, U., Steinbach, J., Scheunemann, M., & Schliebs, R. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.011 · Cited by 48
Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid
Austin, S. A., & Katusic, Z. S. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18822474 · Cited by 52
“Our previous results as well as those from others have demonstrated the ability of endothelial NO to inhibit amyloidogenic processing of APP in both human cells and mouse cerebrovascular tissue.9,11,12,23,30 Vascular dysfunction is a significant feature of CAA and AD.31,32 Endothelial dysfunction is an early event in…”
BackgroundInfluentialPlasma β-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype
Gomis, M., Sobrino, T., Ois, A., Millán, M., Rodríguez-Campello, A., de la Ossa, N. P., Rodríguez-González, R., Jiménez-Conde, J., Cuadrado-Godia, E., Roquer, J., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.559641 · Cited by 52
Park, L., Zhou, P., Koizumi, K., El Jamal, S., Previti, M. L., Van Nostrand, W. E., Carlson, G., & Iadecola, C. (2013) · Stroke · doi:10.1161/strokeaha.112.670976 · Cited by 52
Self-citationEndothelin receptor antagonists: Potential in Alzheimer's disease
Palmer, J. C., & Love, S. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.12.008 · Cited by 52
Aliev, G., Li, Y., H. Palacios, H., & E. Obrenovich, M. (2011) · Recent Patents on Cardiovascular Drug Discovery · doi:10.2174/157489011797376942 · Cited by 51
Caballero, M. Á. A., Song, Z., Rubinski, A., Duering, M., Dichgans, M., Park, D. C., & Ewers, M. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12062 · Cited by 50
Tipping points in neurodegeneration
Simons, M., Levin, J., & Dichgans, M. (2023) · Neuron · doi:10.1016/j.neuron.2023.05.031 · Cited by 50
Mixed dementia: Neglected clinical entity or nosographic artifice?
Fierini, F. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116662 · Cited by 50
Estrous Cycle–Dependent Neurovascular Dysfunction Induced by Angiotensin II in the Mouse Neocortex
Capone, C., Anrather, J., Milner, T. A., & Iadecola, C. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.133249 · Cited by 49
Self-citationHung, V. K., Yeung, P. K., Lai, A. K., Ho, M. C., Lo, A. C., Chan, K. C., Wu, E. X., Chung, S. S., Cheung, C. W., & Chung, S. K. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.109 · Cited by 48
Impaired Peripheral Endothelial Microvascular Responsiveness in Alzheimer's Disease
Khalil, Z., LoGiudice, D., Khodr, B., Maruff, P., & Masters, C. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11106 · Cited by 47
Egger, T., Hammer, A., Wintersperger, A., Goti, D., Malle, E., & Sattler, W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00641.x · Cited by 48
Neurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy
Hamel, É., Royea, J., Ongali, B., & Tong, X. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0285-4 · Cited by 47
Carlsson, C. M., Nondahl, D. M., Klein, B. E. K., McBride, P. E., Sager, M. A., Schubert, C. R., Klein, R., & Cruickshanks, K. J. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181850188 · Cited by 38
Gaertner, R. F., Wyss-Coray, T., Von Euw, D., Lesné, S., Vivien, D., & Lacombe, P. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.11.008 · Cited by 46
Spinocerebellar ataxias caused by polyglutamine expansions: A review of therapeutic strategies
Underwood, B. R., & Rubinsztein, D. C. (2008) · The Cerebellum · doi:10.1007/s12311-008-0026-z · Cited by 44
Aβ Vasoactivity: An Inflammatory Reaction
Paris, D., Town, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06355.x · Cited by 44
P2Y receptors in Alzheimer's disease
Erb, L., Cao, C., Ajit, D., & Weisman, G. A. (2015) · Biology of the Cell · doi:10.1111/boc.201400043 · Cited by 43
Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases
Segura‐Collar, B., Mata-Martínez, P., Hernández‐Laín, A., Gómez, P. S., & Gargini, R. (2021) · The Neuroscientist · doi:10.1177/1073858420985838 · Cited by 43
Roy, S. S., & Rauk, A. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.031 · Cited by 43
Aliev, G., Palacios, H. H., Gasimov, E., Obrenovich, M. E., Morales, L., Leszek, J., Bragin, V., Solís Herrera, A., & Gokhman, D. (2010) · Pharmaceuticals · doi:10.3390/ph3010158 · Cited by 43
Tong, X., & Hamel, É. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039602 · Cited by 43
Differential MRI patterns of brain atrophy in double or single transgenic mice for APP and/or SOD
Borg, J., & Chereul, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21778 · Cited by 42
Büerger, K., Ernst, A. S., Ewers, M., Uspenskaya, O., Omerovic, M., Morgenthaler, N. G., Knauer, K., Bergmann, A., & Hampel, H. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.032 · Cited by 42
Martin, C. J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00211 · Cited by 42
Tayara, N. E. T. E., Delatour, B., Volk, A., & Dhénain, M. (2010) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-009-0194-y · Cited by 42
Atherosclerosis and Neurodegeneration: Unexpected Conspirators in Alzheimer’s Dementia
Iadecola, C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000102660.99744.85 · Cited by 42
Self-citationReactive Oxygen Species in Diabetes-induced Vascular Damage, Stroke, and Alzheimer's Disease
Muhammad, S., Bierhaus, A., & Schwaninger, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0982 · Cited by 41
Olakkaran, S., Anupama, K. P., Antony, A., & Gurushankara, H. P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02546-z · Cited by 41
Perivascular macrophages in the CNS : From health to neurovascular diseases
Li, Z., Guo, Y., Zhai, X., Zhang, Y., Chen, W., Zhu, Z., Xuan, W., & Li, P. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13954 · Cited by 41
Metalloporphyrins as Therapeutic Catalytic Oxidoreductants in Central Nervous System Disorders
Sheng, H., Chaparro, R., Sasaki, T., Izutsu, M., Pearlstein, R. D., Tovmasyan, A. G., & Warner, D. S. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5413 · Cited by 41
CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS
Fissolo, N., Matute-Blanch, C., Osman, M., Costa, C., Pinteac, R., Miró, B., Sanchez, A., Brito, V., Dujmovic, I., Voortman, M., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000941 · Cited by 40
Austin, S. A., Sens, M. A., & Combs, C. K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3107-09.2009 · Cited by 40
Neurovascular and neurometabolic derailment in aging and Alzheimer's disease
Lourenço, C. F., Ledo, A., Dias, C., Barbosa, R. M., & Laranjinha, J. A. N. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00103 · Cited by 40
Göttler, J., Preibisch, C., Riederer, I., Pasquini, L., Alexopoulos, P., Bohn, K. P., Yakushev, I. Y., Beller, E., Kaczmarz, S., Zimmer, C., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18759182 · Cited by 40
Induction of CD40 on human endothelial cells by Alzheimer’s β-amyloid peptides
Tan, J., Town, T., Suo, Z., Wu, Y., Song, S., Kundtz, A., Kroeger, J. L., Humphrey, J., Crawford, F., & MULLAN, M. J. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00122-7 · Cited by 40
Cerebral amyloid angiopathy impact on endothelium
Grinberg, L. T., Korczyn, A. D., & Heinsen, H. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.08.005 · Cited by 39
Cellular Cofactors for Amyloid β-Peptide-Induced Cell Stress
Yan, S. D., Roher, A., Schmidt, A. M., & Stern, D. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65452-1 · Cited by 39
Benek, O., Aitken, L., Hroch, L., Kuca, K., Gunn-Moore, F., & Musilek, K. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150114163051 · Cited by 39
Kimchi, E. Y., Kajdasz, S., Bacskai, B. J., & Hyman, B. T. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.3.274 · Cited by 39
Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration
Hsu, M., Sheu, J., Lin, C., Shen, M., & Hsu, C. Y. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.003 · Cited by 39
Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery
Glassman, P. M., Walsh, L. R., Villa, C. H., Marcos-Contreras, O. A., Hood, E. D., Muzykantov, V. R., & Greineder, C. F. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00003 · Cited by 39
Deficiency of the Copper Chaperone for Superoxide Dismutase Increases Amyloid-β Production
Gray, E. H., Vos, K. J. D., Dingwall, C., Perkinton, M. S., & Miller, C. C. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100717 · Cited by 39
Palmer, J. C., Kehoe, P. G., & Love, S. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01084.x · Cited by 38
Cerebral Circulation: Function and Dysfunction in Alzheimerʼs Disease
Hamel, E. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000177 · Cited by 34
Overexpression of CuZn-SOD Prevents Lipopolysaccharide-Induced Endothelial Dysfunction
Didion, S. P., Kinzenbaw, D. A., Fegan, P. E., Didion, L. A., & Faraci, F. M. (2004) · Stroke · doi:10.1161/01.str.0000132764.06878.c5 · Cited by 37
Badhwar, A., Brown, R., Stanimirovic, D. B., Haqqani, A. S., & Hamel, E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655172 · Cited by 36
Aging enhances vascular dysfunction induced by the Alzheimer's peptide β-amyloid
Price, J. M., Hellermann, A., Hellermann, G., & Sutton, E. T. (2004) · Neurological Research · doi:10.1179/016164104225014003 · Cited by 36
Zeng, X., Sehrawat, A., Lafferty, T. K., Chen, Y., Rawat, M., Kamboh, M. I., Villemagne, V. L., López, O. L., Cohen, A. D., & Karikari, T. K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14535 · Cited by 36
Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative Stress
Austin, S. A., Santhanam, A. V. R., d’Uscio, L. V., & Katušić, Z. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144062 · Cited by 36
d’Uscio, L. V., Das, P., Santhanam, A. V. R., He, T., Younkin, S. G., & Katušić, Z. S. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs266 · Cited by 35
Self-citationStrazielle, C., Sturchler, C., Staufenbiel, M., & Lalonde, R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00037-x · Cited by 35
Nicolakakis, N., Aboulkassim, T., Aliaga, A., Tong, X.-K., Rosa-Neto, P., & Hamel, E. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.78 · Cited by 34
Patella, F., Neilson, L. J., Athineos, D., Erami, Z., Anderson, K. I., Blyth, K., Ryan, K. M., & Zanivan, S. R. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00166 · Cited by 34
Bayer, T. A., & Multhaup, G. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8212 · Cited by 34
Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
Quaegebeur, A., & Carmeliet, P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_83 · Cited by 33
Unfolding the therapeutic potential of chemical chaperones for age-related macular degeneration
Sauer, T. C., Patel, M. M., Chan, C., & Tuo, J. (2008) · Expert Review of Ophthalmology · doi:10.1586/17469899.3.1.29 · Cited by 33
Age-related reduction in visually evoked cerebral blood flow responses
Niehaus, L., Lehmann, R., Röricht, S., & Meyer, B. U. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00212-8 · Cited by 33
Impaired Neurovascular Coupling in the APPxPS1 Mouse Model of Alzheimer’s Disease
Rancillac, A., Geoffroy, H., & Rossier, J. (2012) · Current Alzheimer Research · doi:10.2174/156720512804142859 · Cited by 32
Novel drug development for amyotrophic lateral sclerosis
Hurko, O., & Walsh, F. S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00419-6 · Cited by 32
Zerbi, V., Jansen, D., Dederen, P. J. W. C., Veltien, A. A., Hamans, B. C., Liu, Y., Heerschap, A., & Kiliaan, A. J. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0448-8 · Cited by 31
Manso, Y., Carrasco, J., Comes, G., Adlard, P. A., Bush, A. I., & Hidalgo, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1045-y · Cited by 31
Manso, Y., Comes, G., López, J. C., Belfiore, M., Molinero, A., Giralt, M., Carrasco, J., Adlard, P. A., Bush, A. I., Delgado-Garcia, J. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151025 · Cited by 30
So, K., Li, A., Liang, Y., Zhang, L., Luo, X., Wu, L.-L., Chen, Z.-W., Wei, G.-H., Zhang, K., Du, Z.-A., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.325012 · Cited by 30
Lana, D., Traini, C., Bulli, I., Sarti, G., Magni, G., Attorre, S., Giovannini, M. G., & Vannucchi, M. G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1451114 · Cited by 30
Blunted cerebrovascular response is associated with elevated beta-amyloid
Sisante, J.-F. V., Vidoni, E. D., Kirkendoll, K., Ward, J. L., Liu, Y., Kwapiszeski, S. J., Maletsky, R., Burns, J. M., & Billinger, S. A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17732449 · Cited by 30
Hachinski, V., Einhäupl, K. M., Ganten, D., Alladi, S., Brayne, C., Stephan, B. C. M., Sweeney, M. D., Zloković, B. V., Iturria‐Medina, Y., Iadecola, C., et al. (2019) · International Journal of Stroke · doi:10.1177/1747493019871915 · Cited by 30
Self-citationYin, K., Lee, J., Cheng, H., Xu, J., & Hsu, C. Y. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600139 · Cited by 30
Krezowski, J., Knudson, D., Ebeling, C., Pitstick, R., Giri, R. K., Schenk, D., Westaway, D., Younkin, L., Younkin, S. G., Ashe, K. H., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh210 · Cited by 30
Self-citationSuo, Z., Su, G. C., Placzek, A. N., Kundtz, A., Humphrey, J., Crawford, F., & MULLAN, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06363.x · Cited by 30
Association of cerebral microvascular dysfunction and white matter injury in Alzheimer’s disease
Bagi, Z. A., Kroenke, C. D., Fopiano, K. A., Tian, Y., Filosa, J. A., Sherman, L. S., Larson, E. B., Keene, C. D., Degener-O’Brien, K., Adeniyi, P. A., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00585-5 · Cited by 29
Microvascular degeneration occurs before plaque onset and progresses with age in 3xTg AD mice
Quintana, D. D., Anantula, Y., Garcia, J. A., Engler-Chiurazzi, E. B., Sarkar, S. N., Corbin, D. R., Brown, C. M., & Simpkins, J. W. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.019 · Cited by 29
Princz-Kranz, F. L., Mueggler, T., Knobloch, M., Nitsch, R. M., & Rudin, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.002 · Cited by 28
“Aβ-CAA has been shown to affect endothelium-dependent vasoactivity in a global manner associated with compromised cerebral circulation (Iadecola et al., 1999, Iadecola, 2003; Shin et al., 2007).”
BackgroundBottley, A., Phillips, N. M., Webb, T. E., Willis, A. E., & Spriggs, K. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013030 · Cited by 28
Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula
Lu, K., Yamada, S., Hernandez, M. C., Croatt, A. J., Grande, J. P., Juncos, J. P., Vercellotti, G. M., Hebbel, R. P., Katušić, Z. S., Terzic, A., et al. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00311.2011 · Cited by 28
Peripheral Routes to Neurodegeneration: Passing Through the Blood–Brain Barrier
Giannoni, P., Claeysen, S., Noè, F. M., & Marchi, N. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00003 · Cited by 27
Daulatzai, M. A. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9643-3 · Cited by 27
Vascular Actions of Estrogen and Alzheimer's Disease
Thomas, T., & Rhodin, J. A. G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06406.x · Cited by 27
Vascular Changes in Iowa‐Type Hereditary Cerebral Amyloid Angiopathy
Shin, Y., Cho, H. S., Rebeck, G. W., & Greenberg, S. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04822.x · Cited by 27
Nakane, H., Chu, Y., Faraci, F. M., Oberley, L. W., & Heistad, D. D. (2001) · Stroke · doi:10.1161/01.str.32.1.184 · Cited by 27
Sleep–wake architecture in mouse models for Down syndrome
Colas, D., London, J., Gharib, A., Cespuglio, R., & Sarda, N. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.009 · Cited by 26
Bosentan preserves endothelial function in mice overexpressing APP
Elesber, A. A., Bonetti, P. O., Woodrum, J. E., Zhu, X.-Y., Lerman, L. O., Younkin, S. G., & Lerman, A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.012 · Cited by 26
Self-citationMajláth, Z., Toldi, J., & Vécsei, L. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1135-5 · Cited by 25
Metadata
- Authors
- Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A.
- Affiliations
- University of Minnesota (US)
- Mayo Clinic (US)
- McLaughlin Research Institute (US)
- National Institutes of Health (US)
- Johns Hopkins University (US)
- Corresponding author
- Iadecola, Costantino
- ORCID
- Venue
- Nature Neuroscience
- Published
- 1999-02
- Volume
- 2
- Issue
- 2
- Pages
- 157-161
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- DOI
- 10.1038/5715
- OpenAlex
- W1525061277
- Cited by
- 399
- References
- 46
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 16 · 2019: 17 · 2018: 10 · 2017: 11 · 2016: 16 · 2015: 18 · 2014: 19 · 2013: 18 · 2012: 18
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS-37853, R01NS035806, NS34179, NS-35806, R01NS037853)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- superoxide dismutase 1, amyloid precursor protein, APP overexpression, cerebral microcirculation, Alzheimer's disease, amyloid-beta, cerebral blood flow, neocortex, transgenic mice
- MeSH terms
- Superoxide Dismutase-1, Animals, Cerebral Cortex, Cerebrovascular Circulation, Endothelium, Vascular, Humans, Mice, Transgenic, Superoxide Dismutase, Vasoconstrictor Agents, Free Radical Scavengers, Amyloid beta-Protein Precursor, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.